Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
Among 13 core symptoms across 3,106 breast, colorectal, prostate, and lung cancer patients, persons with lung cancer were the most symptomatic, with moderate to severe fatigue being reported with the greatest prevalence. This is a proposed randomized controlled trial of a novel rehabilitative intervention for persons with non-small cell lung cancer after surgery that promotes self-management of cancer-related fatigue (CRF) and is practical, portable, low cost, and safe. The results of the study will provide a novel exercise intervention, and its optimal timing, that helps a vulnerable population by reducing CRF severity and fatigability and is applicable to nearly all post-thoracotomy lung cancer patients.
Checked against the public recordLast updated Feb 24, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Nebraska
- Interventions being studied
- Behavioral: Light Physical Activity 1; Behavioral: Light Physical Activity 2; Behavioral: Support Education Activity
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Women and men * At least 18 years of age (Michigan) and 19 years of age in (Nebraska) * With suspected non-small cell lung cancer to be confirmed after surgery * Karnofsky Performance Status score of at least 70% * Thoracic surgeon approval pre- and post-surgery * Medically stable comorbid conditions allowing for non-small cell lung cancer surgery clearance * Has phone access capability * Able to speak and write English * Able to hear and speak for phone interviews * Owns a television * Lives within 2 hours driving distance of recruitment site Exclusion Criteria: * Severe impairment of sight, hearing, speaking * Active treatment for malignancy within past 3 months (other than non-melanoma skin cancer or long-term hormonal treatment for common cancers such as breast and prostate if disease is stable * Weight greater than 330 pounds * History of photosensitive seizures * Any condition or disorder that would impede safe participation as directed * Plans to relocate outside the area during the study period or unable to fully participate
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Nebraska Medical CenterOmaha, Nebraska
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 24, 2026. Always confirm current availability with the study team.